Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 31801-31850 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06072339
Optimization of Positive End Expiratory Pressure by Use of Pulmonary Ultrasound for Patients With Blunt Chest Trauma Treated by Non-Invasive Ventilation (Opti-PEP).
NARecruiting
40 participants
Started: Dec 19, 2023 · Completed: Dec 26, 2025
2 conditions1 sponsor1 location
NCT06490861
Performance of the Paragit Sleeve to Measure and Monitor Motor Symptoms in Patients With Parkinson's Disease
NARecruiting
25 participants
Started: Dec 19, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06129175
UCMSCs as Treatment for Patients With Acute Ischemic Stroke (Stroke Neuroncell-EX)
PHASE2/PHASE3Recruiting
80 participants
Started: Dec 19, 2023 · Completed: May 31, 2025
1 condition2 sponsors1 location
NCT06839950
Sensory Profile and Early Clinical Signs of Calm Room Users
N/ARecruiting
80 participants
Started: Dec 19, 2023 · Completed: May 19, 2028
3 conditions1 sponsor1 location
NCT06445439
Optimal Pacing Rate for Cardiac Resynchronization Therapy
NARecruiting
60 participants
Started: Dec 19, 2023 · Completed: Aug 31, 2025
1 condition2 sponsors5 locations
NCT06127199
Contraceptive Efficacy Study of Ovaprene
NARecruiting
656 participants
Started: Dec 19, 2023 · Completed: Sep 30, 2026
1 condition2 sponsors25 locations
NCT06318923
Social and Moral Cognition in Multiple Sclerosis
NARecruiting
90 participants
Started: Dec 19, 2023 · Completed: Oct 30, 2025
1 condition1 sponsor2 locations
NCT06989190
The MIND Study - Microangiopathy IN Diabetes
N/ARecruiting
400 participants
Started: Dec 19, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05933980
Toripalimab,Celecoxib and Regorafenib in the Treatment of Refractory Advanced Colorectal Cancer
PHASE2Recruiting
44 participants
Started: Dec 19, 2023 · Completed: Dec 20, 2025
3 conditions1 sponsor1 location
NCT05955170
Tucatinib in Combination With Oral Etoposide andTrastuzumab in Patients With Metastatic HER2+ Breast Cancer
PHASE2Recruiting
66 participants
Started: Dec 19, 2023 · Completed: Dec 19, 2028
1 condition2 sponsors13 locations
NCT06016920
Safety and Efficacy of VB10.16 and Pembrolizumab in Patients with Head-Neck Squamous Cell Carcinoma
PHASE1/PHASE2Recruiting
51 participants
Started: Dec 19, 2023 · Completed: Jan 31, 2028
2 conditions2 sponsors17 locations
NCT06174610
Changes of Renal Resistive Index in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.
N/ARecruiting
50 participants
Started: Dec 19, 2023 · Completed: Dec 18, 2026
1 condition1 sponsor1 location
NCT06415162
Evaluation of the Effects of Using Cooling Pillowcases, on the Symptoms of Hot Flushes, Sleep and Life Quality
NARecruiting
64 participants
Started: Dec 19, 2023 · Completed: Jul 31, 2024
1 condition1 sponsor1 location
NCT06576024
Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in HIV-infected People
PHASE4Recruiting
400 participants
Started: Dec 19, 2023 · Completed: Dec 20, 2024
3 conditions2 sponsors1 location
NCT06372587
Next-Generation alzheImer'S Therapeutics
NARecruiting
14 participants
Started: Dec 19, 2023 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT06238089
Anti-psychotic Drug Prescribing Patterns Within Specialist Adult ID Services in England and Wales
N/ARecruiting
600 participants
Started: Dec 19, 2023 · Completed: Apr 30, 2024
1 condition1 sponsor8 locations
NCT06144762
Precision Imaging for Early Detection and Targeted Treatment Monitoring in Pancreatic Cancer
NARecruiting
150 participants
Started: Dec 19, 2023 · Completed: Oct 31, 2029
1 condition1 sponsor1 location
NCT05912075
Preoperative Radiotherapy And ASTX660 in Rectum Cancer
PHASE1Recruiting
78 participants
Started: Dec 19, 2023 · Completed: Jan 31, 2029
1 condition1 sponsor2 locations
NCT06214936
Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield
NARecruiting
252 participants
Started: Dec 19, 2023 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT06071286
SEQUENTIAL PROFILING OF TUMOR-DERIVED CIRCULATING CELL-FREE DNA (ctDNA) IN ADVANCED OVARIAN CANCER PATIENTS
NARecruiting
30 participants
Started: Dec 19, 2023 · Completed: Oct 30, 2026
1 condition1 sponsor1 location
NCT06084195
Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging
NARecruiting
120 participants
Started: Dec 19, 2023 · Completed: Oct 31, 2029
1 condition1 sponsor1 location
NCT06190366
Effects of Bloodletting Acupuncture for Subacute and Chronic Non-specific Low Back Pain
NARecruiting
108 participants
Started: Dec 19, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05383495
Anxiolysis for Laceration Repair in Children
PHASE3Recruiting
300 participants
Started: Dec 19, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06153459
Cord Clamping Among Neonates With Congenital Heart Disease
NARecruiting
500 participants
Started: Dec 19, 2023 · Completed: Dec 31, 2030
1 condition11 sponsors21 locations
NCT06028334
GetUp&Go: A Randomized Controlled Trial of an Intervention to Enhance Physical Activity After TBI
NARecruiting
70 participants
Started: Dec 19, 2023 · Completed: Aug 31, 2027
1 condition2 sponsors1 location
NCT05845593
Relationship Between Data Obtained With the LuGENE® Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients With SLE (ReLATE)
N/ARecruiting
200 participants
Started: Dec 19, 2023 · Completed: Mar 5, 2025
1 condition1 sponsor11 locations
NCT06040762
A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial
NARecruiting
128 participants
Started: Dec 19, 2023 · Completed: Oct 30, 2026
4 conditions2 sponsors1 location
NCT06164119
Effects of Diet and Osteopathy on Quality of Life and Inflammation in Breast Cancer Patients Under Hormonal Therapy
NARecruiting
600 participants
Started: Dec 19, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06585007
Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer
PHASE3Recruiting
246 participants
Started: Dec 19, 2023 · Completed: Jan 20, 2029
2 conditions1 sponsor1 location
NCT06381219
Pediatric Eosinophilic Esophagitis (pedEoE): Effect of Allergen Heat Denaturation on EoE Remission: a Pilot Trial
NARecruiting
36 participants
Started: Dec 19, 2023 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT05933889
Single and Combined Modality Trans-Oral Robotic Surgery in Early Oropharyngeal Cancer
N/ARecruiting
250 participants
Started: Dec 19, 2023 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT06092346
A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders
N/ARecruiting
999 participants
Started: Dec 19, 2023 · Completed: Jan 1, 2099
28 conditions1 sponsor1 location
NCT05828511
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
PHASE1/PHASE2Recruiting
132 participants
Started: Dec 19, 2023 · Completed: Nov 2, 2035
1 condition1 sponsor30 locations
NCT06384105
Study of the Patient Radiation Dose During Five Endourological Procedures
NARecruiting
870 participants
Started: Dec 19, 2023 · Completed: Dec 18, 2024
2 conditions1 sponsor2 locations
NCT06409182
A Prospective Pilot Study to Evaluate the Diagnostic Performance of a Wireless Sensor Capsule in Detection of UGIB
NARecruiting
30 participants
Started: Dec 19, 2023 · Completed: May 30, 2025
1 condition1 sponsor1 location
NCT06090669
Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency
PHASE1Recruiting
75 participants
Started: Dec 19, 2023 · Completed: Oct 30, 2027
2 conditions1 sponsor1 location
NCT06252493
Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
N/ARecruiting
25 participants
Started: Dec 19, 2023 · Completed: Dec 19, 2025
1 condition2 sponsors1 location
NCT06082102
Efficacy and Safety of Orelabrutinib Combined With Rituximab Versus Lenalidomide Combined With Rituximab in Patients With Relapsed/Refractory Marginal Zone Lymphoma
PHASE3Recruiting
324 participants
Started: Dec 19, 2023 · Completed: Feb 25, 2030
1 condition1 sponsor19 locations
NCT06197451
Validity and Reliability of a Turkish Version of MD Anderson Inventory Dysphagia Inventory
N/ARecruiting
170 participants
Started: Dec 19, 2023 · Completed: May 19, 2024
2 conditions1 sponsor1 location
NCT06175494
A Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Booster Vaccination With Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell)
PHASE3Recruiting
4,800 participants
Started: Dec 19, 2023 · Completed: Jan 31, 2025
1 condition2 sponsors1 location
NCT06129552
Basal Instincts: Towards Better Understanding of Basal Cell Function in Chronic Rhinosinusitis With Nasal Polyps
N/ARecruiting
300 participants
Started: Dec 19, 2023 · Completed: Dec 31, 2027
2 conditions2 sponsors1 location
NCT06220786
Low Level Laser Therapy for Better Wound Healing
NARecruiting
50 participants
Started: Dec 19, 2023 · Completed: Jun 1, 2024
1 condition1 sponsor1 location
NCT05950022
Clinical Improvement Obtained by Endoscopic Ilio-Psoas Tenotomy (Lesser Trochanter Versus Acetabular Notch)
NARecruiting
108 participants
Started: Dec 19, 2023 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT06315400
Efficacy and Safety of Ingavirin®, Capsules, 60 mg, in Children With Influenza and Other Acute Respiratory Viral Infections
PHASE4Recruiting
80 participants
Started: Dec 19, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor3 locations
NCT05334004
Lopinavir/Ritonavir in PLWH With High-Grade AIN
PHASE1Recruiting
21 participants
Started: Dec 19, 2023 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT05938296
OHSV2-PD-L1/CD3-BsAb Administered Via Intratumoral Injection
PHASE1Recruiting
29 participants
Started: Dec 19, 2023 · Completed: Jan 1, 2026
1 condition1 sponsor2 locations
NCT06007729
ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
PHASE2Recruiting
170 participants
Started: Dec 18, 2023 · Completed: Dec 12, 2027
1 condition1 sponsor25 locations
NCT05761964
Harmony & Health: Feasibility of a Movement Intervention to Improve Psychosocial Wellbeing in Black Adults in Northeast Texas
NARecruiting
54 participants
Started: Dec 18, 2023 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT06123026
Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion
PHASE4Recruiting
200 participants
Started: Dec 18, 2023 · Completed: Jun 30, 2024
2 conditions1 sponsor1 location
NCT06187506
Disitamab Vedotin Combined With BCG Therapy in HER2-expressing High-risk Non-muscle Invasive Bladder Cancer
PHASE2Recruiting
20 participants
Started: Dec 18, 2023 · Completed: Jan 31, 2027
2 conditions1 sponsor1 location